Loading
Haematologist specialising in leukaemia who has directed Institut Paoli-Calmettes, the Marseille comprehensive cancer centre, since May 2022.
Norbert Vey is Directeur Général of Institut Paoli-Calmettes (IPC), the Centre de Lutte Contre le Cancer in Marseille, accredited as a Comprehensive Cancer Center by the OECI. He took office on 13 May 2022 for a five-year term following a ministerial decree, succeeding Patrice Viens, who had led the institute since 2007. He is a professor of haematology at Aix-Marseille University and a hospital practitioner specialising in the treatment of leukaemia, and previously directed the institute's haematology department.
| Title | Journal | Year |
|---|---|---|
| Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study | The Lancet Haematology | 2016 |
| Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia | New England Journal of Medicine | 2016 |
| Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia | Therapeutic Advances in Hematology | 2020 |
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tags leadership, clinician-scientist.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tags leadership, clinician-scientist.
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, haematology.